{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:11:12Z","timestamp":1786119072755,"version":"build-2736575974"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,1,1]]},"DOI":"10.1097\/qai.0b013e31818ffcdc","type":"journal-article","created":{"date-parts":[[2008,12,16]],"date-time":"2008-12-16T03:40:27Z","timestamp":1229398827000},"page":"1-8","source":"Crossref","is-referenced-by-count":18,"title":["Prevalence of Drug-Resistant HIV-1 in Rural Areas of Hubei Province in the People's Republic of China"],"prefix":"10.1097","volume":"50","author":[{"given":"Minqi","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongrong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po","family":"Tien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linqi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xien","family":"Gui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"11","key":"R1-1-20210131","doi-asserted-by":"crossref","first-page":"e443","DOI":"10.1371\/journal.pmed.0030443","article-title":"Dominance of HIV-1 subtype CRF01_AE in sAE in sexually acquired cases leads to a new epidemic in Yunnan province of China.","volume":"3","author":"Zhang","year":"2006","journal-title":"PLoS Med"},{"key":"R2-1-20210131","doi-asserted-by":"crossref","first-page":"13591","DOI":"10.1128\/JVI.78.24.13591-13599.2004","article-title":"Molecular characterization of human immunodeficiency virus type 1 and hepatitis C virus in paid blood donors and injection drug users in China.","volume":"78","author":"Zhang","year":"2004","journal-title":"J Virol"},{"key":"R3-1-20210131","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/00126334-200308150-00015","article-title":"High prevalence of HIV infection among women and their children in Henan province, China.","volume":"33","author":"Zhuang","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R4-1-20210131","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1097\/00002030-200311210-00015","article-title":"HIV-1 subtype B dictates the AIDS epidemic among paid blood donors in the Henan and Hubei provinces of China.","volume":"17","author":"Su","year":"2003","journal-title":"AIDS"},{"key":"R5-1-20210131","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1089\/apc.2005.19.848","article-title":"Sexually transmitted disease\/HIV and heterosexual risk among miners in townships of Yunnan province, China.","volume":"19","author":"Zhao","year":"2005","journal-title":"AIDS Patient Care STDS"},{"key":"R6-1-20210131","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/sj.cr.7290363","article-title":"Care of HIV-infected patients in China.","volume":"15","author":"Cao","year":"2005","journal-title":"Cell Res"},{"key":"R7-1-20210131","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/QAI.0b013e31803133ac","article-title":"The diagnosis and treatment of HIV-infected children in China: challenges and opportunities.","volume":"44","author":"Zhang","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R8-1-20210131","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1177\/135965350601100807","article-title":"HIV-1 transmission cluster with M41L singleton mutation and decreased transmission of resistance in newly diagnosed Swedish homosexual men.","volume":"11","author":"Lindstrom","year":"2006","journal-title":"Antivir Ther"},{"key":"R9-1-20210131","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1097\/00029330-200612010-00010","article-title":"Overview of HIV drug resistance and its implications for China.","volume":"119","author":"Zhang","year":"2006","journal-title":"Chin Med J (Engl)"},{"key":"R10-1-20210131","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/sj.cr.7290362","article-title":"Current progress of Chinas free ART program.","volume":"15","author":"Zhang","year":"2005","journal-title":"Cell Res"},{"key":"R11-1-20210131","first-page":"52","article-title":"HIV sequence databases.","volume":"5","author":"Kuiken","year":"2003","journal-title":"AIDS Rev"},{"key":"R12-1-20210131","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1093\/nar\/gkg100","article-title":"Human immunodeficiency virus reverse transcriptase and protease sequence database.","volume":"31","author":"Rhee","year":"2003","journal-title":"Nucleic Acids Res"},{"key":"R13-1-20210131","first-page":"119","article-title":"Update of the drug resistance mutations in HIV-1: 2007.","volume":"15","author":"Johnson","year":"2007","journal-title":"Top HIV Med"},{"key":"R14-1-20210131","first-page":"125","article-title":"Update of the drug resistance mutations in HIV-1: fall 2006.","volume":"14","author":"Johnson","year":"2006","journal-title":"Top HIV Med"},{"issue":"Suppl 1","key":"R15-1-20210131","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1086\/505356","article-title":"Rationale and uses of a public HIV drug-resistance database.","volume":"194","author":"Shafer","year":"2006","journal-title":"J Infect Dis"},{"key":"R16-1-20210131","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/QAD.0b013e328011e691","article-title":"HIV-1 protease and reverse transcriptase mutations for drug resistance surveillance.","volume":"21","author":"Shafer","year":"2007","journal-title":"AIDS"},{"key":"R17-1-20210131","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1097\/QAD.0b013e328011ec53","article-title":"HIV drug resistance surveillance for prioritizing treatment in resource-limited settings.","volume":"21","author":"Walensky","year":"2007","journal-title":"AIDS"},{"key":"R18-1-20210131","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1086\/499044","article-title":"Response to antiretroviral therapy in HIV-infected patients attending a public, urban clinic in Kampala, Uganda.","volume":"42","author":"Spacek","year":"2006","journal-title":"Clin Infect Dis"},{"key":"R19-1-20210131","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1086\/496984","article-title":"Should resistance testing be performed for treatment-naive HIV-infected patients? A cost-effectiveness analysis.","volume":"41","author":"Sax","year":"2005","journal-title":"Clin Infect Dis"},{"key":"R20-1-20210131","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/sj.cr.7290356","article-title":"Prevalence and evolution of drug resistance HIV-1 variants in Henan, China.","volume":"15","author":"Li","year":"2005","journal-title":"Cell Res"},{"key":"R21-1-20210131","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1097\/00029330-200612010-00006","article-title":"Phenotypic resistance of resistant strains of HIV type-1 subtype B in China.","volume":"119","author":"Li","year":"2006","journal-title":"Chin Med J (Engl)"},{"key":"R22-1-20210131","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/01.qai.0000243049.27580.cc","article-title":"Genotype and phenotype patterns of drug-resistant HIV-1 subtype B (Thai B) isolated from patients failing antiretroviral therapy in China.","volume":"44","author":"Ma","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R23-1-20210131","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1097\/00002030-200107060-00008","article-title":"Development of drug resistance in patients receiving combinations of zidovudine, didanosine and nevirapine.","volume":"15","author":"Conway","year":"2001","journal-title":"AIDS"},{"key":"R24-1-20210131","first-page":"123","article-title":"Strategies for overcoming resistance in HIV-1 infected patients receiving HAART.","volume":"6","author":"Clotet","year":"2004","journal-title":"AIDS Rev"},{"key":"R25-1-20210131","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00002030-200202150-00008","article-title":"Usefulness of monitoring HIV drug resistance and adherence in individuals failing highly active antiretroviral therapy: a randomized study (ARGENTA).","volume":"16","author":"Cingolani","year":"2002","journal-title":"AIDS"},{"key":"R26-1-20210131","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/QAI.0b013e31814278c0","article-title":"Predictors of long-term viral failure among Ugandan children and adults treated with antiretroviral therapy.","volume":"46","author":"Kamya","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R27-1-20210131","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1468-1293.2007.00463.x","article-title":"Performance of a World Health Organization first-line regimen (stavudine\/lamivudine\/nevirapine) in antiretroviral-naive individuals in a western setting.","volume":"8","author":"Tam","year":"2007","journal-title":"HIV Med"},{"key":"R28-1-20210131","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1089\/vim.2006.0047","article-title":"Evaluation of human immunodeficiency virus type 1-infected Chinese patients treated with highly active antiretroviral therapy for two years.","volume":"20","author":"Zhou","year":"2007","journal-title":"Viral Immunol"},{"key":"R29-1-20210131","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1177\/135965350400900301","article-title":"Persistence of multidrug-resistant HIV-1 without antiretroviral treatment 2 years after sexual transmission.","volume":"9","author":"Delaugerre","year":"2004","journal-title":"Antivir Ther"},{"key":"R30-1-20210131","first-page":"7","article-title":"The Global HIV Drug Resistance Surveillance Program: a partnership between WHO and IAS. International AIDS Society.","volume":"16","author":"Havlir","year":"2002","journal-title":"AIDS"},{"key":"R31-1-20210131","first-page":"709","article-title":"Transmitted multidrug resistant HIV-1: new and investigational therapeutic approaches.","volume":"7","author":"Shet","year":"2006","journal-title":"Curr Opin Investig Drugs"},{"key":"R32-1-20210131","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1097\/00002030-200207260-00008","article-title":"Evolving patterns of HIV-1 resistance to antiretroviral agents in newly infected individuals.","volume":"16","author":"Simon","year":"2002","journal-title":"AIDS"},{"key":"R33-1-20210131","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/S0140-6736(05)71139-9","article-title":"Infection with multidrug resistant, dual-tropic HIV-1 and rapid progression to AIDS: a case report.","volume":"365","author":"Markowitz","year":"2005","journal-title":"Lancet"},{"key":"R34-1-20210131","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1177\/135965350601100210","article-title":"Antiviral efficacy and genotypic resistance patterns of combination therapy with stavudine\/tenofovir in highly active antiretroviral therapy experienced patients.","volume":"11","author":"Antinori","year":"2006","journal-title":"Antivir Ther"},{"key":"R35-1-20210131","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ijantimicag.2006.08.026","article-title":"The activity of protease inhibitors against Giardia duodenalis and metronidazole-resistant Trichomonas vaginalis.","volume":"29","author":"Dunn","year":"2007","journal-title":"Int J Antimicrob Agents"},{"key":"R36-1-20210131","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1097\/QAD.0b013e32802e6bfa","article-title":"Treatment interruptions predict resistance in HIV-positive individuals purchasing fixed-dose combination antiretroviral therapy in Kampala, Uganda.","volume":"21","author":"Oyugi","year":"2007","journal-title":"AIDS"},{"key":"R37-1-20210131","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s10461-006-9101-y","article-title":"Adherence to generic reverse transcriptase inhibitor-based antiretroviral medication at a tertiary center in north India.","volume":"11","author":"Wanchu","year":"2007","journal-title":"AIDS Behav"}],"container-title":["JAIDS Journal of Acquired Immune Deficiency Syndromes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/QAI.0b013e31818ffcdc","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:27:20Z","timestamp":1786037240000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00126334-200901010-00001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1,1]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/qai.0b013e31818ffcdc","relation":{},"ISSN":["1525-4135"],"issn-type":[{"value":"1525-4135","type":"print"}],"subject":[],"published":{"date-parts":[[2009,1,1]]}}}